share_log

藥明康德:海外監管公告

WUXI APPTEC: Overseas Regulatory Notice

HKEX ·  Sep 10 10:10
Summary by Moomoo AI
药明康德於2024年9月10日召開董事會,通過以集中竞价交易方式回购A股股份的议案,並將回购的股份全部注销,減少注册资本。本次回购资金总额为人民币10亿元,预计回购股份数量约为16,388,069股,約占已发行总股本的0.56%。公司亦通知债权人,自公告披露之日起45日內申报债权,並要求清偿或提供相应担保。债权申报可於2024年9月11日起45日內進行。
药明康德於2024年9月10日召開董事會,通過以集中竞价交易方式回购A股股份的议案,並將回购的股份全部注销,減少注册资本。本次回购资金总额为人民币10亿元,预计回购股份数量约为16,388,069股,約占已发行总股本的0.56%。公司亦通知债权人,自公告披露之日起45日內申报债权,並要求清偿或提供相应担保。债权申报可於2024年9月11日起45日內進行。
On September 10, 2024, WuXi AppTec held a board of directors meeting and approved a proposal to repurchase A-shares through centralized competitive bidding, and all repurchased shares will be canceled to reduce registered capital. The total amount of this repurchase is 1 billion yuan, and the estimated number of repurchased shares is about 16,388,069 shares, accounting for approximately 0.56% of the total issued share capital. The company also notified creditors to declare their debts within 45 days from the date of announcement disclosure and requested repayment or provision of corresponding guarantees. Debt claims can be made within 45 days starting from September 11, 2024.
On September 10, 2024, WuXi AppTec held a board of directors meeting and approved a proposal to repurchase A-shares through centralized competitive bidding, and all repurchased shares will be canceled to reduce registered capital. The total amount of this repurchase is 1 billion yuan, and the estimated number of repurchased shares is about 16,388,069 shares, accounting for approximately 0.56% of the total issued share capital. The company also notified creditors to declare their debts within 45 days from the date of announcement disclosure and requested repayment or provision of corresponding guarantees. Debt claims can be made within 45 days starting from September 11, 2024.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more